SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-018473
Filing Date
2021-03-30
Accepted
2021-03-30 07:56:25
Documents
96
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_immucellcorp.htm 10-K 813001
2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE f10k2020ex4-2_immucell.htm EX-4.2 28064
3 AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND BO f10k2020ex10-12_immucell.htm EX-10.12 12716
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2020ex23-1_immucell.htm EX-23.1 2486
5 CERTIFICATION f10k2020ex31_immucell.htm EX-31 8978
6 CERTIFICATION f10k2020ex32_immucell.htm EX-32 5580
  Complete submission text file 0001213900-21-018473.txt   5152482

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE iccc-20201231.xml EX-101.INS 843586
8 XBRL SCHEMA FILE iccc-20201231.xsd EX-101.SCH 66476
9 XBRL CALCULATION FILE iccc-20201231_cal.xml EX-101.CAL 77070
10 XBRL DEFINITION FILE iccc-20201231_def.xml EX-101.DEF 177298
11 XBRL LABEL FILE iccc-20201231_lab.xml EX-101.LAB 470954
12 XBRL PRESENTATION FILE iccc-20201231_pre.xml EX-101.PRE 348796
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12934 | Film No.: 21783666
SIC: 2835 In Vitro & In Vivo Diagnostic Substances